Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aflibercept (zaltrap) (1 trial)
rbm-007 (1 trial)
trafermin (2 trials)
Macular Degeneration (Phase 2)
Trials (3 total)
Trial APIs (3 total)